Literature DB >> 28421696

Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs?

Anna Olsen1, David McDonald1,2, Simon Lenton3, Paul M Dietze4.   

Abstract

The Bradford Hill criteria for assessing causality are useful in assembling evidence, including within complex policy analyses. In this paper, we argue that the implementation of take-home naloxone (THN) programs in Australia and elsewhere reflects sensible, evidence-based public health policy, despite the absence of randomised controlled trials. However, we also acknowledge that the debate around expanding access to THN would benefit from a careful consideration of causal inference and health policy impact of THN program implementation. Given the continued debate around expanding access to THN, and the relatively recent access to new data from implementation studies, two research groups independently conducted Bradford Hill analyses in order to carefully consider causal inference and health policy impact. Hill's criteria offer a useful analytical tool for interpreting current evidence on THN programs and making decisions about the (un)certainty of THN program safety and effectiveness.
© 2017 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  Bradford Hill; naloxone; opioid; overdose; policy

Mesh:

Substances:

Year:  2017        PMID: 28421696     DOI: 10.1111/dar.12523

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  2 in total

1.  An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine.

Authors:  Paul Dietze; Gilberto Gerra; Vladimir Poznyak; Giovanna Campello; Wataru Kashino; Dzhonbek Dzhonbekov; Tetiana Kiriazova; Danil Nikitin; Assel Terlikbayeva; Dzmitry Krupchanka; Anja Busse
Journal:  Bull World Health Organ       Date:  2022-02-03       Impact factor: 9.408

2.  Hospital admissions among people who inject opioids following syringe services program implementation.

Authors:  K J Bornstein; A E Coye; J E St Onge; H Li; A Muller; T S Bartholomew; H E Tookes
Journal:  Harm Reduct J       Date:  2020-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.